Buscar resultados de ensayos clínicos
Cholangitis - 111 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2016-01-08 Intervenciones: Drug: Cenicriviroc 150 mg One tablet of CVC 150 mg once daily taken with food in the morning |
Withdrawn |
Nombre del estudio: The Value of CT Cholangiography in Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2007-12-26 Intervenciones: Procedure: CT cholangiography Cholografin 20ml will be diluted in 100 ml of normal saline and infused ov |
Completed |
Nombre del estudio: Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2012-03-11 |
Recruiting |
Nombre del estudio: Swiss Primary Sclerosing Cholangitis Cohort Study Condición: Cholangitis, Sclerosing Fecha: 2017-05-08 |
Completed |
Nombre del estudio: Trial of High-dose Urso in Primary Sclerosing Cholangitis Condición: Sclerosing Cholangitis Fecha: 2003-04-21 Intervenciones: Drug: Ursodeoxycholic Acid |
Recruiting |
Nombre del estudio: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Condición: Primary Biliary Cholangitis (PBC) Fecha: 2017-03-28 Intervenciones:
|
Completed |
Nombre del estudio: Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2010-03-12 Intervenciones: Drug: ursodeoxycholic acid (UDCA) Pediatric PSC patients already receiving UDCA therapy will enter a fou |
Recruiting |
Nombre del estudio: A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2014-09-04 Intervenciones: Drug: BTT1023 IV (in the vein) Investigational Medicinal Product (IMP) |
Recruiting |
Nombre del estudio: Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid Condición: Primary Biliary Cholangitis Fecha: 2017-03-24 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis Condición: Primary Biliary Cholangitis Fecha: 2017-05-11 Intervenciones: Drug: APD334 APD334 active treatment for 24 weeks. O |